Orchestra BioMed Holdings, Inc.OBIOEarnings & Financial Report
Nasdaq · Health Care · Surgical & Medical Instruments & Apparatus
Orchestra BioMed Holdings, Inc. is a clinical-stage medical technology company focused on developing novel, evidence-based therapeutic solutions for cardiovascular and other high-burden chronic diseases. It collaborates with leading healthcare stakeholders, operates primarily across North American and European markets, with core segments covering interventional cardiology and chronic disease care optimization.
Top Holders
| Holder | % Owned | Shares | Change | As of |
|---|---|---|---|---|
| RTW Investments, LP | 21.50% | 7.7M | — | 2024-08-07 |
| Medtronic plc | 16.40% | 5.9M | — | 2024-02-14 |
| RTW | 15.70% | 5.6M | — | 2023-05-05 |
| Perceptive Advisors LLC | 12.80% | 4.6M | ▲ +6.00pp | 2024-07-17 |
| BlackRock, Inc. | 5.10% | 1.9M | flat | 2024-11-08 |
| HSAC | 4.80% | 1.7M | — | 2024-08-07 |
| T. ROWE PRICE ASSOCIATES, INC. | 1.70% | 622.6K | — | 2024-02-14 |
Insider Transactions
Net 90d: +$42.9K · buys $42.9K / sells $0Range:
Action:
Role:
| Insider | Role | Action | ||||
|---|---|---|---|---|---|---|
| 2026-03-13 | Hochman David P | See Remarks | Buy (open market) | 10.0K | $4.29 | $42.9K |
| 2026-02-12 | Darren Sherman | See Remarks | Grant | 397.0K | $0.00 | $0 |
| 2026-02-12 | Taylor Andrew Lawrence | Chief Financial Officer | Grant | 181.0K | $0.00 | $0 |
| 2026-02-12 | Hochman David P | See Remarks | Grant | 504.0K | $0.00 | $0 |
1–4 of 4